The European Union has finally approved the use of anti-viral drug, Remdesivir, which has been claimed to cure coronavirus.
The approval came after two major US studies showed that remdesivir can reduce the duration of hospital stay for COVID-19 patients.
In a press statement on Friday, July 3rd, 2020, EU Health Commissioner Stella Kyriakides revealed that the approval of the vaccine is an important step taken to fight the spread of Covid-19.
She stated as follows;
“Today’s authorisation of a first medicine to treat COVID-19 is an important step forward in the fight against this virus.
We are granting this authorisation less than a month after the application was submitted, showing clearly the EU’s determination to respond quickly whenever new treatments become available.”
Remdesivir which is the only anti-coronavirus medication to be given the green light in the EU, was originally intended as a treatment for Ebola.